These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 13727350)

  • 21. [On the duration of circulation in the blood and excretion in the urine of C14-labeled sarcolysin following intravenous administration to rabbits].
    NOVIKOVA MA; CHESTUKHIN AV
    Biull Eksp Biol Med; 1961 Aug; 52():56-9. PubMed ID: 13729778
    [No Abstract]   [Full Text] [Related]  

  • 22. AN EXPERIMENTAL STUDY OF TISSUE-CONCENTRATION RATIOS OF AS74 ARSENATE AND LABELED ORGANIC CONJUGATES.
    MCQUEEN JD; MEGO JL
    J Neurosurg; 1964 Aug; 21():641-6. PubMed ID: 14197092
    [No Abstract]   [Full Text] [Related]  

  • 23. INTRA-ARTERIAL VINCRISTINE THERAPY OF PRIMARY GLIOMAS.
    OWENS G; JAVID R; BELMUSTO L; BENDER M; BLAU M
    Cancer; 1965 Jun; 18():756-60. PubMed ID: 14297472
    [No Abstract]   [Full Text] [Related]  

  • 24. [RESORPTION, DISTRIBUTION AND EXCRETION OF RADIOACTIVE-LABELLED 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN) IN ANIMAL EXPERIMENTS].
    KOLB KH; KRAMER M; SCHULZE PE
    Arzneimittelforschung; 1964 May; 14():385-9. PubMed ID: 14238595
    [No Abstract]   [Full Text] [Related]  

  • 25. Preferential attack on cancer following major cancer surgery.
    Knock FE; Galt RM; Oester YT; Sylvester R; Renaud OV
    Int Surg; 1971 Feb; 55(2):104-9. PubMed ID: 5545535
    [No Abstract]   [Full Text] [Related]  

  • 26. COMPARATIVE PHARMACOLOGY OF ALKYLATING AGENTS. II. THERAPEUTIC ACTIVITIES OF ALKYLATING AGENTS AND REFERENCE COMPOUNDS AGAINST VARIOUS TUMOR SYSTEMS.
    SCHMIDT LH; FRADKIN R; SULLIVAN R; FLOWERS A
    Cancer Chemother Rep; 1965 Jan; 18():SUPPL 2:403+. PubMed ID: 14278902
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical pharmacokinetics of drugs used in the treatment of breast cancer.
    Wiebe VJ; Benz CC; DeGregorio MW
    Clin Pharmacokinet; 1988 Sep; 15(3):180-93. PubMed ID: 3052986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The distribution, excretion and metabolism of hydroxyurea-C14.
    Adamson RH; Ague SL; Hess SM; Davidson JD
    J Pharmacol Exp Ther; 1965 Nov; 150(2):322-34. PubMed ID: 5858620
    [No Abstract]   [Full Text] [Related]  

  • 29. ALKYLATING AGENTS AND IODOPHOR COMPOUNDS FOR THE PREVENTION OF LOCAL RECURRENCE OF CANCER.
    VERNICK JJ; MAGELL J; HOPPE ET
    Surg Forum; 1964; 15():336-8. PubMed ID: 14189397
    [No Abstract]   [Full Text] [Related]  

  • 30. [THE EFFECT OF ALKYLATING CYTOSTATICS ON THE NUCLEIC ACID METABOLISM OF EHRLICH ASCITES TUMOR CELLS].
    LISS E; PALME G
    Z Krebsforsch; 1964 Jul; 66():196-206. PubMed ID: 14256642
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on OPSPA. III. Distribution and excretion of radioactivity following administration of OPSPA-C14 and OPSPA-P32 to humans.
    MALLER RK; MCIVER FA; HEIDELBERGER C
    Cancer Res; 1957 May; 17(4):291-5. PubMed ID: 13427009
    [No Abstract]   [Full Text] [Related]  

  • 32. [Assay of anti-cancer drug sensitivity of cells from human tumors. Detection of cell viability with radioisotope (author's transl)].
    Ishii M; Yamamuro T; Takeda T
    Nihon Seikeigeka Gakkai Zasshi; 1982 Apr; 56(4):293-304. PubMed ID: 7097093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lymphatic delivery of drugs and its application to cancer chemotherapy (author's transl)].
    Muranishi S
    Yakugaku Zasshi; 1980 Jul; 100(7):687-98. PubMed ID: 7009828
    [No Abstract]   [Full Text] [Related]  

  • 34. An in vitro transcription assay for probing drug-DNA interactions during active transcription of DNA.
    Phillips DR; Crothers DM
    Methods Mol Biol; 1995; 37():89-105. PubMed ID: 7540091
    [No Abstract]   [Full Text] [Related]  

  • 35. [Metabolism of antitumor agent [14C] antimony nitrilotriacetic acid in mice (author's transl)].
    Chen RT; Shen ML; Hua Z; Yan QY; Xu B
    Zhongguo Yao Li Xue Bao; 1981 Sep; 2(3):211-4. PubMed ID: 6462016
    [No Abstract]   [Full Text] [Related]  

  • 36. [Distribution and metabolism of a with C-14 labeled cytostatic drug in the organisms].
    Jászsági-Nagy E; Elekes I
    Strahlentherapie; 1968 Jun; 135(6):688-92. PubMed ID: 5682133
    [No Abstract]   [Full Text] [Related]  

  • 37. [COMPARATIVE STUDY OF THE SPECTRUM OF ACTION OF ANTINEOPLASTIC PREPARATIONS OF THE ALKYLATING AGENT GROUP ON TRANSPLANTABLE TUMORS IN MICE].
    BOKAEVA SS
    Biull Eksp Biol Med; 1965 Mar; 59():86-8. PubMed ID: 14310877
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies on OPSPA. II. Distribution and excretion of radioactivity following administration of OPSPA-C14 and OPSPA-P32 to the rat.
    MALLER RK; HEIDELBERGER C
    Cancer Res; 1957 May; 17(4):284-90. PubMed ID: 13427008
    [No Abstract]   [Full Text] [Related]  

  • 39. Antineoplastic and immunosuppressive drugs. I. Biochemical and clinical pharmacological considerations.
    Chalmers AH; Burgoyne LA; Murray AW
    Drugs; 1972; 3(3):227-53. PubMed ID: 4561638
    [No Abstract]   [Full Text] [Related]  

  • 40. Initial studies on the disposition of quinolinium dibromide (NSC-176319) in mice and rats.
    Plowman J; Adamson RH
    Pharmacology; 1978; 17(2):61-8. PubMed ID: 684077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.